The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
Open accessAbstract
BACKGROUND: It is desirable to prescribe the minimal effective dose of inhaled steroids to control asthma. To ensure that inflammation is suppressed whilst using the lowest possible dose, a sensitive and specific method for assessing airway inflammation is needed. METHODS: The usefulness of exhaled nitric oxide (NO), sputum eosinophils, and methacholine airway responsiveness (PC20) for monitoring airway inflammatory changes following four weeks of treatment with an inhaled corticosteroid (budesonide via Turbohaler) were compared. Mild stable steroid naive asthmatic subjects were randomised into two double blind, placebo controlled studies. The first was a parallel group study involving three groups receiving either 100 micrograms/day budesonide (n = 8), 400 micrograms/day budesonide (n = 7), or a matched placebo (n = 6). The second was a crossover study involving 10 subjects randomised to receive 1600 micrograms budesonide or placebo. The groups were matched with respect to age, PC20, baseline FEV1 (% predicted), exhaled NO, and sputum eosinophilia. RESULTS: There were significant improvements in FEV1 following 400 micrograms and 1600 micrograms budesonide (11.3% and 6.5%, respectively, p < 0.05). This was accompanied by significant reductions in eosinophil numbers in induced sputum (0.7 and 0.9 fold, p < 0.05). However, levels of exhaled NO were reduced following each budesonide dose while PC20 was improved only with 1600 micrograms budesonide. These results suggest that exhaled NO and PC20 may not reflect the control of airway inflammation as accurately as the number of eosinophils in sputum. There were dose dependent changes in exhaled NO, sputum eosinophils, and PC20 to inhaled budesonide but a plateau response of exhaled NO was found at a dose of 400 micrograms daily. CONCLUSION: Monitoring the number of eosinophils in induced sputum may be the most accurate guide to establish the minimum dose of inhaled steroids needed to control inflammation. This, however, requires further studies involving a larger number of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
Standardization of bronchial inhalation challenge procedures
Chai, H., Farr, R. S., Froehlich, L. A., Mathison, D. A., McLean, J. A., Rosenthal, R. R., Sheffer, A. L., Spector, S. L., & Townley, R. G. (1975) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(75)90107-4 · Cited by 1,453
Increased nitric oxide in exhaled air of asthmatic patients
Kharitonov, S. A., Yates, D., Robbins, R. A., Barnes, P. J., Logan-Sinclair, R., & Shinebourne, E. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90931-8 · Cited by 1,436
Self-citationPizzichini, E., Pizzichini, M. M., Efthimiadis, A., Evans, S., Morris, M. M., Squillace, D., Gleich, G. J., Dolovich, J., & Hargreave, F. E. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.2.8756799 · Cited by 966
Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma
Haahtela, T., Jarvinen, M., Kava, T., Kiviranta, K., Koskinen, S., Lehtonen, K., Nikander, K., Persson, T., Selroos, O., Sovijarvi, A., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409153311103 · Cited by 743
Jatakanon, A., Lim, S., Kharitonov, S. A., Chung, K. F., & Barnes, P. J. (1998) · Thorax · doi:10.1136/thx.53.2.91 · Cited by 688
Self-citationJuniper, E. F., Kline, P. A., Vanzieleghem, M. A., Ramsdale, E. H., O'byrne, P. M., & Hargreave, F. E. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.4.832 · Cited by 602
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.
Kharitonov, S. A., Yates, D. H., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542158 · Cited by 580
Self-citationEffects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings, V. M., Jatakanon, A., Worsdell, Y. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032192 · Cited by 558
Self-citationAllergic respiratory disease: strategic targets for primary prevention during childhood
Holt, P. G., & Sly, P. D. (1997) · Thorax · doi:10.1136/thx.52.1.1 · Cited by 464
Van Essen-Zandvliet, E. E., Hughes, M. D., Waalkens, H. J., Duiverman, E. J., Pocock, S. J., Kerrebijn, K. F., & The Dutch Chronic Non-Specific Lung Disease Study Group (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.3.547 · Cited by 456
Kerstjens, H. A. M., Brand, P. L. P., Hughes, M. D., Robinson, N. J., Postma, D. S., Sluiter, H. J., Bleecker, E. R., Dekhuijzen, P. N. R., de Jong, P. M., Mengelers, H. J. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272003 · Cited by 341
Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract.
Kharitonov, S. A., Chung, K. F., Evans, D., O'Connor, B. J., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665033 · Cited by 287
Self-citationGlucocorticoids inhibit cytokine-mediated eosinophil survival
Wallen, N., Kita, H., Weiler, D., & Gleich, G. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3490 · Cited by 265
Bronchial Subepithelial Fibrosis Correlates With Airway Responsiveness to Methacholine
Boulet, L.-P., Laviolette, M., Turcotte, H., Cartier, A., Dugas, M., Malo, J.-L., & Boutet, M. (1997) · Chest · doi:10.1378/chest.112.1.45 · Cited by 255
Sont, J. K., Han, J., van Krieken, J. M., Evertse, C. E., Hooijer, R., Willems, L. N., & Sterk, P. J. (1996) · Thorax · doi:10.1136/thx.51.5.496 · Cited by 237
Pizzichini, E., Pizzichini, M. M., Efthimiadis, A., Dolovich, J., & Hargreave, F. E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70082-4 · Cited by 229
GIBSON, P. G., WONG, B. J. O., HEPPERLE, M. J. E., KLINE, P. A., GIRGIS‐GABARDO, A., GUYATT, G., DOLOVICH, J., DENBURG, J. A., RAMSDALE, E. H., & HARGREAVE, F. E. (1992) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1992.tb00161.x · Cited by 198
in 't Veen, J., de Gouw, H., Smits, H., Sont, J., Hiemstra, P., Sterk, P., & Bel, E. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122441 · Cited by 187
Busse, W. W., Chervinsky, P., Condemi, J., Lumry, W. R., Petty, T. L., Rennard, S., & Townley, R. G. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70353-7 · Cited by 185
Time Course of Change in Bronchial Reactivity with an Inhaled Corticosteroid in Asthma
Vathenen, A. S., Knox, A. J., Wisniewski, A., & Tattersfield, A. E. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.6.1317 · Cited by 181
Corrigan, C. J., Hamid, Q. A., North, J. M., Barkans, J. R., Moqbel, R., Durham, S. R., Gemou-Engesæth, V., & Kay, A. B. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.5.7742019 · Cited by 146
Effect of High Dose Inhaled Fluticasone Propionate on Airway Inflammation in Asthma
Booth, H., Richmond, I., Ward, C., Gardiner, P. V., Harkawat, R., & Walters, E. H. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599861 · Cited by 142
Comparison of two methods of collecting induced sputum in asthmatic subjects
Gershman, N. H., Wong, H., Liu, J., Mahlmeister, M. J., & Fahy, J. V. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122448 · Cited by 126
Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor
Lamas, A. M., Leon, O., & Schleimer, R. P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.254 · Cited by 124
Hallsworth, M. P., Litchfield, T. M., & Lee, T. H. (1992) · PubMed · Cited by 61
New Guidelines for Diagnosis and Management of Asthma
Sly, R. M. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63229-2 · Cited by 57
Cited by
Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,918
Nitric oxide in health and disease of the respiratory system
Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) · Physiological Reviews · doi:10.1152/physrev.00034.2003 · Cited by 903
Exhaled Markers of Pulmonary Disease
KHARITONOV, S. A., & BARNES, P. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2009041 · Cited by 844
Self-citationA Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750
Exhaled nitric oxide measurements: clinical application and interpretation
Taylor, D. R., Pijnenburg, M. W., Smith, A. D., & Jongste, J. C. D. (2006) · Thorax · doi:10.1136/thx.2005.056093 · Cited by 507
Metadata
- Authors
- Jatakanon, A., Kharitonov, S., Lim, S., & Barnes, P. J.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1999-02-01
- Volume
- 54
- Issue
- 2
- Pages
- 108-114
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2101211836
- Cited by
- 262
- References
- 30
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.